TGCT
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Comparative Study of the Efficacy of Multimodal Interventions for Tenosynovitis (NCT06709911) | Zixin Deng | 2024-12-01 |
| Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) (NCT05417789) | SynOx Therapeutics Limited | 2024-10-09 |
| A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT (NCT05349643) | AmMax Bio, Inc. | 2023-01-26 |
| Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCT (NCT05277454) | Hutchison Medipharma Limited | 2022-01-18 |
| A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients (NCT04938180) | AmMax Bio, Inc. | 2021-09-16 |
Track TGCT automatically
Every clearance here is in the API, with alerts when new ones post.